(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USOS DE LURBINECTEDINA NO TRATAMENTO DE MESOTELIOMA MALIGNO

ArquivadaInvention PatentPCT · EP2020074689
Talk to an expert

Application data

Number

112022003149

Type

Invention Patent

Filing

09/03/2020

Publication

05/17/2022

PCT

EP2020074689
View on INPI

Progress at the INPI

  1. Filing09/03/20
  2. Publication05/17/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/26/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PHARMA MAR, S.A.

ES

See this company's full portfolio

Inventors

I. M. (pessoa física)

CH

R. M. (pessoa física)

CH

Technical data

IPC Classification

A61K 31/4995A61K 38/00A61K 45/06A61P 35/00

Priority claims

EP

19382749.0 · 09/03/2019

Abstract

LURBINECTEDINA NO TRATAMENTO DE MESOTELIOMA MALIGNO. A presente invenção refere-se ao uso de lurbinectedina no tratamento de mesotelioma maligno é fornecido.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

05/26/2026

RPI 2890

Parecer de pré-exame

#6.23

01/27/2026

RPI 2873

Notificação de entrada na fase nacional - PCT

#1.3

05/17/2022

RPI 2680

Alteração de dados cadastrais

#1.1

03/03/2022

RPI 2669

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.